3 Results for "

CI-M6PR

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CI-M6PR" in MCE Product Catalog:

Cat. No.: HY-181430
CAS No.: 798546-78-8
Target:  

TGF-beta/Smad

PXS 25 is a cation-independent mannose 6-phosphate receptor (CI-M6PR) inhibitor that inhibits CI-M6PR-mediated activation of latent TGF-β1. PXS 25 inhibits conversion of high glucose-induced latent TGF-β1 to active TGF-β1 in proximal tubule cells under normoxic conditions. PXS 25 suppresses high glucose-induced fibronectin, collagen IV production, and phosphorylated Smad 2 in proximal tubule cells under normoxic conditions. PXS 25 has antifibrotic properties in skin fibroblasts. PXS 25 can be used for the research of diabetic nephropathy .
loading...
    loading...
Cat. No.: HY-RS06622
Research Areas:  

Others

IGF2R Human Pre-designed siRNA Set A contains three designed siRNAs for IGF2R gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-181431
CAS No.: 1253691-50-7
Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology

PXS 64, a mannose-6-phosphate (M6P) analogue. a lipophilic prodrug of PXS 25 (HY-181430). PXS 64 is an effective anti-fibrotic agent by inhibiting the activation of latent TGF-β1. PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts. PXS 64 reduces TGFβ-mediated collagen IV, fibronectin, MCP-1, and phospho-smad2 expression in kidney cells. PXS 64 reduces collagen deposition in dermal scar fibroblasts. PXS 64 can be used for the research of chronic kidney disease, idiopathic pulmonary fibrosis, scarring .
loading...
    loading...